Status:
COMPLETED
The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265)
Lead Sponsor:
Organon and Co
Conditions:
Rhinitis, Allergic, Perennial
Eligibility:
All Genders
15-85 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine the effect of an approved medication on the symptoms of perennial allergic rhinitis (an inflammation of the mucous membrane of the nose similar to that found ...
Eligibility Criteria
Inclusion
- Non-smoker with a 2-year documented history of perennial allergic (symptoms that persist throughout the year) rhinitis symptoms and positive allergy testing
Exclusion
- Medical history of a lung disorder (other than asthma) or a recent upper respiratory tract infection
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2004
Estimated Enrollment :
1992 Patients enrolled
Trial Details
Trial ID
NCT00092118
Start Date
October 1 2003
End Date
May 1 2004
Last Update
February 3 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.